Should venom AIT be stopped during the COVID-19 pandemic?
AIT should continue in non-infected patients or those recovered from
COVID-19. This is especially important in patients with life-threatening
conditions such as venom allergy. It is possible to extend the intervals
between vaccines during subcutaneous AIT, as done for inhalant
allergens, to minimize visits to the allergy clinic. If venom AIT was
stopped due to SARS-CoV-2 infection, it is unclear when it should be
re-initiated because data from convalescent patients is
scarce.118